Posted by: Market Watch in Market Information 23 minutes in the past Shares of Novavax Inc. have been down 6.2% in buying and selling on Mo
Shares of Novavax Inc. have been down 6.2% in buying and selling on Monday after the corporate stated it had accomplished enrollment of the Section Three scientific trial for its COVID-19 vaccine candidate in Mexico and the U.S. Novavax stated that 20% of the roughly 30,000 trial members are LatinX, 13% are African People, 6% are Native People, and 5% are Asian People. Individually, 13% of all trial members are 65 years outdated or older. Novavax’s experimental vaccine requires two doses, spaced 21 days aside. The corporate final monthdisclosed preliminary findings from a late-stage trial of the identical vaccine that’s being performed in the UK. Novavax’s inventory has soared 3,289.1% over the previous 12 months, whereas the broader S&P 500 is up 15.3%.Market Pulse Tales are Fast-fire, brief information bursts on shares and markets as they transfer. Go to MarketWatch.com for extra info on this information.
Learn Full Story
